Clinical Trial Update: 18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors

View source ↗

Summary

This ClinicalTrials.gov entry describes a recruiting study evaluating 18F-FAPI-04 PET/CT and PET/MR imaging in patients with various malignant tumors. The spons…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 18F-FAPI-04 (Fluorine-18 labeled fibroblast activation protein inhibitor FAPI-04)

Snippet

Sponsor: Hunan Cancer Hospital | Conditions: Cancer, FAP | Status: RECRUITING